Daniel E. Greenleaf, President and CEO at VioQuest Pharmaceuticals, Inc. (VQPH), bought 17,500 shares at $0.56 ($10K) on 2007-02-16, disclosed to the SEC on 2007-02-20.
Open-market purchase of $10k VQPH by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.56 | 2,500 | $1K | 14.1% |
| 2 | $0.57 | 15,000 | $9K | 85.9% |
| Total | $0.57 avg | 17,500 | $10K | 100% |
| Filing → |
| BIOS | BUY | 2016-11-14 | $21K | — | Filing → |
| VQPH | BUY | 2007-02-16 | $1K | — | Filing → |
| VQPH | BUY | 2006-04-06 | $9K | — | Filing → |